{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:04:38Z","timestamp":1778018678231,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan","award":["20K12669 to S.H."],"award-info":[{"award-number":["20K12669 to S.H."]}]},{"name":"Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan","award":["22H02828 to M.O."],"award-info":[{"award-number":["22H02828 to M.O."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89615-8","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T09:52:12Z","timestamp":1739353932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Changes of leucine-rich alpha 2 glycoprotein could be a marker of changes of endoscopic and histologic activity of ulcerative colitis"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuki","family":"Aoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Yasutomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junki","family":"Toyosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kinugasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"89615_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.2010.224154","volume":"60","author":"C Mowat","year":"2011","unstructured":"Mowat, C. et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 60, 571\u2013607 (2011).","journal-title":"Gut"},{"key":"89615_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","volume":"133","author":"KF Fr\u00f8slie","year":"2007","unstructured":"Fr\u00f8slie, K. F., Jahnsen, J., Moum, B. A. & Vatn, M. H. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 133, 412\u2013422 (2007).","journal-title":"Gastroenterology"},{"key":"89615_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10620-013-2907-3","volume":"59","author":"JY Yoon","year":"2014","unstructured":"Yoon, J. Y. et al. Correlations of creactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis. Dig. Dis. Sci. 59, 829\u2013837 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"89615_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/ajg.2012.315","volume":"108","author":"A Nakarai","year":"2013","unstructured":"Nakarai, A. et al. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test. Am. J. Gastroenterol. 108, 83\u201389 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"89615_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ajg.2015.66","volume":"110","author":"S Takashima","year":"2015","unstructured":"Takashima, S. et al. Evaluation of mucosal healing in ulcerative colitis by fecal calprotectin vs. fecal immunochemical test. Am. J. Gastroenterol. 110, 873\u2013880 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"89615_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.11622\/smedj.2013077","volume":"54","author":"WS Tan","year":"2013","unstructured":"Tan, W. S., Tang, C. L. & Koo, W. H. Opportunistic screening for colorectal neoplasia in Singapore using faecal immunochemical occult blood test. Singap. Med. J. 54, 220\u2013223 (2013).","journal-title":"Singap. Med. J."},{"key":"89615_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ypmed.2013.05.017","volume":"57","author":"MC Wong","year":"2013","unstructured":"Wong, M. C. et al. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong. Prev. Med. 57, 227\u2013231 (2013).","journal-title":"Prev. Med."},{"key":"89615_CR8","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.3748\/wjg.v20.i17.4994","volume":"20","author":"FS Lehmann","year":"2014","unstructured":"Lehmann, F. S. et al. Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma. World J. Gastroenterol. 20, 4994\u20134999 (2014).","journal-title":"World J. Gastroenterol."},{"key":"89615_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N Engl. J. Med. 340, 448\u2013454 (1999).","journal-title":"N Engl. J. Med."},{"key":"89615_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/13497413.2018.1481582","volume":"41","author":"T Naka","year":"2018","unstructured":"Naka, T. & Fujimoto, M. LRG is a novel inflammatory marker clinically useful for the evaluation of disease activity in rheumatoid arthritis and inflammatory bowel disease. Immunol. Med. 41, 62\u201367 (2018).","journal-title":"Immunol. Med."},{"key":"89615_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12929-022-00790-6","volume":"29","author":"C Camilli","year":"2022","unstructured":"Camilli, C., Hoeh, A. E., De Rossi, G. D., Moss, S. E. & Greenwood, J. LRG1: an emerging player in disease pathogenesis. J. Biomed. Sci. 29, 6 (2022).","journal-title":"J. Biomed. Sci."},{"key":"89615_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1189\/jlb.72.3.478","volume":"72","author":"LC O\u2019Donnell","year":"2002","unstructured":"O\u2019Donnell, L. C., Druhan, L. J. & Avalos, B. R. Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. J. Leukoc. Biol. 72, 478\u2013485 (2002).","journal-title":"J. Leukoc. Biol."},{"key":"89615_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.bbrc.2009.03.104","volume":"382","author":"R Shirai","year":"2009","unstructured":"Shirai, R., Hirano, F., Ohkura, N., Ikeda, K. & Inoue, S. Up-regulation of the expression of leucine-rich alpha2-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem. Biophys. Res. Commun. 382, 776\u2013779 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"89615_CR14","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1002\/ibd.22936","volume":"18","author":"S Serada","year":"2012","unstructured":"Serada, S. et al. Serum leu cine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflamm. Bowel Dis. 18, 2169\u20132179 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"89615_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/ard.2009.118919","volume":"69","author":"S Serada","year":"2010","unstructured":"Serada, S. et al. iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann. Rheum. Dis. 69, 770\u2013774 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"89615_CR16","doi-asserted-by":"publisher","first-page":"11086","DOI":"10.1038\/s41598-021-90441-x","volume":"11","author":"E Yasutomi","year":"2021","unstructured":"Yasutomi, E. et al. Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease. Sci. Rep. 11, 11086 (2021).","journal-title":"Sci. Rep."},{"key":"89615_CR17","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/ibd\/izac230","volume":"29","author":"T Shimoyama","year":"2022","unstructured":"Shimoyama, T., Yamamoto, T., Yoshiyama, S., Nishikawa, R. & Umegae, S. Leucine-Rich Alpha-2 glycoprotein is a Reliable serum biomarker for evaluating clinical and endoscopic Disease Activity in Inflammatory Bowel Disease. Inflamm. Bowel Dis. 29, 1399\u20131408 (2022).","journal-title":"Inflamm. Bowel Dis."},{"key":"89615_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00535-021-01793-0","volume":"56","author":"S Shinzaki","year":"2021","unstructured":"Shinzaki, S. et al. Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study. J. Gastroenterol. 56, 560\u2013569 (2021).","journal-title":"J. Gastroenterol."},{"key":"89615_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.5217\/ir.2023.00135","volume":"22","author":"R Karashima","year":"2024","unstructured":"Karashima, R. et al. Early change in serum leucine-rich \u03b1-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis. Intest Res. 22, 473\u2013483 (2024).","journal-title":"Intest Res."},{"key":"89615_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5009\/gnl17013","volume":"15","author":"S Hiraoka","year":"2018","unstructured":"Hiraoka, S. et al. Fecal immunochemical test and fecal calprotectin results show different profiles in Disease Monitoring for Ulcerative Colitis. Gut Liver. 15, 142\u2013148 (2018).","journal-title":"Gut Liver"},{"key":"89615_CR21","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.3390\/jcm12227165","volume":"12","author":"Y Tatsumi","year":"2023","unstructured":"Tatsumi, Y. et al. Biomarkers for monitoring of changes in Disease Activity in Ulcerative Colitis. J. Clin. Med. 12, 7165 (2023).","journal-title":"J. Clin. Med."},{"key":"89615_CR22","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder, K. W., Tremaine, W. J. & Ilstrup, D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl. J. Med. 317, 1625\u20131629 (1987).","journal-title":"N Engl. J. Med."},{"key":"89615_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cgh.2020.11.040","volume":"20","author":"C Ma","year":"2022","unstructured":"Ma, C. et al. Modeling endoscopic improvement after induction treatment with mesalamine in patients with mild-to-moderate Ulcerative Colitis. Clin. Gastroenterol. Hepatol. 20, 447\u2013454 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"89615_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","volume":"61","author":"SP Travis","year":"2012","unstructured":"Travis, S. P. et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 61, 535\u2013542 (2012).","journal-title":"Gut"},{"key":"89615_CR25","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.cgh.2020.09.017","volume":"12","author":"F Magro","year":"2021","unstructured":"Magro, F. et al. Histologic Features of Colon Biopsies (Geboes score) Associated with Progression of Ulcerative Colitis for the First 36 months after Biopsy. Clin. Gastroenterol. Hepatol. 12, 2567\u20132576 (2021).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"89615_CR26","doi-asserted-by":"crossref","unstructured":"Yoshimura, T. et al. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease. Mediators Inflamm. 8825374 (2021). (2021).","DOI":"10.1155\/2021\/8825374"},{"key":"89615_CR27","doi-asserted-by":"publisher","first-page":"12431","DOI":"10.1038\/s41598-021-90558-z","volume":"11","author":"N Ishida","year":"2021","unstructured":"Ishida, N. et al. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis. Sci. Rep. 11, 12431 (2021).","journal-title":"Sci. Rep."},{"key":"89615_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3164\/jcbn.18-92","volume":"64","author":"H Sonoyama","year":"2019","unstructured":"Sonoyama, H. et al. Capabilities of fecal calprotectin and blood biomarkers as surrogate endoscopic markers according to ulcerative colitis disease type. J. Clin. Biochem. Nutr. 64, 265\u2013270 (2019).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"89615_CR29","first-page":"26","volume":"9","author":"A Lasson","year":"2015","unstructured":"Lasson, A. et al. The intraindividual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis. J. Crohns Colitis 9, 26\u201332 (2015).","journal-title":"J. Crohns Colitis"},{"key":"89615_CR30","first-page":"2683","volume":"96","author":"E Husebye","year":"2001","unstructured":"Husebye, E., Ton, H. & Johne, B. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm. Am. J. Gastroenterol. 96, 2683\u20132687 (2001).","journal-title":"Am. J. Gastroenterol."},{"key":"89615_CR31","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1097\/MIB.0000000000000349","volume":"21","author":"M Calafat","year":"2015","unstructured":"Calafat, M. et al. High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling? Inflamm. Bowel Dis. 21, 1072\u20131076 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"89615_CR32","doi-asserted-by":"publisher","first-page":"c3369","DOI":"10.1136\/bmj.c3369","volume":"341","author":"PF van Rheenen","year":"2010","unstructured":"van Rheenen, P. F., Van de Vijver, E. & Fidler, V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 341, c3369 (2010).","journal-title":"BMJ"},{"key":"89615_CR33","first-page":"468","volume":"37","author":"UL Fagerberg","year":"2003","unstructured":"Fagerberg, U. L., L\u00f6\u00f6f, L., Merzoug, R. D., Hansson, L. O. & Finkel, Y. Fecal calprotectin levels in healthy children studied with an improved assay. J. Pediatr. Gastroenterol. Nutr. 37, 468\u2013472 (2003).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"89615_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.gie.2012.03.169","volume":"76","author":"ST Van Turenhout","year":"2012","unstructured":"Van Turenhout, S. T. et al. Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results. Gastrointest. Endosc. 76, 136\u2013143 (2012).","journal-title":"Gastrointest. Endosc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89615-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89615-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89615-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T09:52:22Z","timestamp":1739353942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89615-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89615"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89615-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4231663\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"7 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5248"}}